xy0206
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Oct 31, 2018 (NCT03658070)
Timeline
Indications
Mechanism of action
FLT3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07162116 | Phase 1 | Jul 6, 2025 | Yiling Pharmaceutical Inc. |
| NCT06823232 | Phase 1 | Nov 6, 2024 | Yiling Pharmaceutical Inc. |
| NCT05876832 | Phase 3 | Jun 15, 2023 | Yiling Pharmaceutical Inc. |
| NCT04471064 | Phase 1 | Sep 15, 2020 | Chinese Academy of Medical Sciences, Proswell Medical Corporation, Yiling Pharmaceutical Inc. |
| NCT03658070 | Phase 1 | Oct 31, 2018 | Chinese Academy of Medical Sciences, Yiling Pharmaceutical Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yiling Pharmaceutical Inc. | For profit | 5 | 5 | 2 | 2018 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2018 |
| Proswell Medical Corporation | For profit | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1